Freudenberger Ronald S, Carson Jeffrey L
Heart Failure and Transplant Cardiology Program, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Curr Opin Crit Care. 2003 Oct;9(5):356-61. doi: 10.1097/00075198-200310000-00004.
Anemia is common in patients admitted to the cardiac intensive care unit. Many unique issues must be considered in the treatment of the anemic cardiac patient. Coronary artery disease and left ventricular dysfunction may significantly increase the risk of anemia. These patients have limited reserve because of a high extraction ratio of oxygen in the cardiac circulation. Left ventricular dysfunction increases the risk of complications from transfusion. Recent observational studies suggest that cardiac patients may benefit from a higher transfusion threshold. However, very few patients with cardiovascular disease have been included in clinical trials comparing high and low transfusion triggers. Experimental data and recent studies in humans suggest that cardiac patients may be intolerant of anemia. Pending definitive clinical trials in cardiac patients, we suggest a more aggressive transfusion trigger (9-10 g/dL) in patients with active cardiac disease. Pulmonary edema may be precipitated by transfusion in patients with left ventricular dysfunction. Large clinical trials are urgently needed to determine optimal transfusion thresholds in patients with cardiovascular disease.
贫血在入住心脏重症监护病房的患者中很常见。在治疗贫血性心脏病患者时,必须考虑许多独特的问题。冠状动脉疾病和左心室功能障碍可能会显著增加贫血风险。由于心脏循环中氧气的提取率很高,这些患者的储备有限。左心室功能障碍会增加输血并发症的风险。最近的观察性研究表明,心脏病患者可能会从更高的输血阈值中获益。然而,在比较高输血触发值和低输血触发值的临床试验中,纳入的心血管疾病患者非常少。实验数据和近期的人体研究表明,心脏病患者可能无法耐受贫血。在针对心脏病患者的确定性临床试验之前,我们建议对患有活动性心脏病的患者采用更积极的输血触发值(9 - 10 g/dL)。左心室功能障碍患者输血可能会引发肺水肿。迫切需要进行大规模临床试验,以确定心血管疾病患者的最佳输血阈值。